COVID-19–Sensitive Tumour Response – 2-Year Assessment of the SARS-CoV-2 Humoral Response in Cancer Patients in Oncology Hospital in Poland
Published: Jan. 19, 2024
Background:
So
far,
vaccination
has
been
considered
the
most
crucial
defense
against
viral
infection,
including
SARS-CoV-2.
Numerous
reports
have
demonstrated
effectiveness
of
above
vaccines
in
oncology
patients.
It
also
proven
that,
apart
from
vaccinations
and
oncological
therapy,
course
cancer
process
itself
influences
magnitude
humoral
response,
especially
people
after
infection
with
Objective:
This
study
aimed
to
answer
question
about
impact
on
response
patients
vaccinated
SARS-CoV-2
COVID-19.
Material
methods:
1,668
were
observed.
Over
two
years,
5,082
IgG
IgM
antibody
samples
determined.
The
concentration
antibodies
was
assessed
three
groups
patients:
those
undergoing
anticancer
therapy
contracting
COVID-19
infection.
Results:
obtained
results
indicate
a
naturally
more
significant
who
not
undergone
such
as
radiotherapy,
chemotherapy,
or
surgical
intervention.
observation
applies
breast,
lung,
colon
cancer,
although
varies
significantly
depending
type
cancer.
Summary:
size
presence
specific
directed
SARS-CoV-2,
IgM,
IgG,
supply
vaccine
antigen
COVID-19,
is
an
indicator
adequate
immune
protection
reinfection.
highlights
for
first
time
phenomenon
increased
certain
types
that
are
assumed
be
sensitive
initiation
which,
according
generally
accepted
principles,
blocked
by
we
observe
seems
confirm
"natural"
defence
potential
patient's
body,
this
case,
pathogen.
A
"stronger"
antiviral
explain
asymptomatic
some
remains
open
what
extent
weakened
these
Language: Английский
COVID-19–Sensitive Tumour Response – 2-year Assessment of the SARS-CoV-2 Humoral Response in Cancer Patients in Oncology Hospital in Poland
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 13, 2024
Abstract
Vaccination
has
been
considered
the
most
crucial
defence
against
viral
infection,
including
SARS-CoV-2.
Numerous
reports
have
demonstrated
effectiveness
of
above
vaccines
in
oncology
patients.
It
also
proven
that,
apart
from
vaccinations
and
oncological
therapy,
course
cancer
process
itself
influences
magnitude
humoral
response,
especially
people
after
infection
with
The
phenomenon
we
observe
seems
to
confirm
presence
a
"natural"
potential
patient's
body,
this
case,
directed
pathogen.
A
"stronger"
antiviral
response
explains
asymptomatic
SARS-CoV-2
some
To
what
extent
weakened
anticancer
these
patients
remains
an
open
question.
Objective:
This
study
aimed
answer
question
about
impact
on
vaccinated
COVID-19.
Material
methods:
1,668
were
observed.
Over
two
years,
5,082
IgG
IgM
antibody
samples
determined.
concentration
antibodies
was
assessed
groups
patients:
those
undergoing
therapy
contracting
COVID-19
vaccination
infection.
Results:
The
obtained
results
indicate
naturally
more
significant
who
not
undergone
such
as
radiotherapy,
chemotherapy,
or
surgical
intervention.
observation
applies
breast,
lung,
colon,
kidney
testicular
cancer,
although
varies
significantly
depending
type
cancer.
Language: Английский
COVID-19–sensitive tumour response: 2-year assessment of the SARS-CoV-2 humoral response in cancer patients in oncology hospital in Poland
Cancer Immunology Immunotherapy,
Journal Year:
2024,
Volume and Issue:
74(1)
Published: Dec. 21, 2024
Abstract
Vaccination
has
been
considered
the
most
crucial
defence
against
viral
infections,
including
SARS-CoV-2.
Numerous
reports
have
demonstrated
effectiveness
of
above
vaccines
in
oncological
patients.
It
also
proven
that,
apart
from
vaccinations
and
therapy,
course
cancer
process
itself
influences
magnitude
humoral
response,
especially
people
after
infection
with
The
phenomenon
we
observe
seems
to
confirm
presence
a
"natural"
potential
patient's
body,
this
case,
directed
pathogen.
A
"stronger"
antiviral
response
explains
asymptomatic
SARS-CoV-2
some
To
what
extent
weakened
anticancer
these
patients
remains
an
open
question.
Objective
This
study
aimed
answer
question
about
impact
on
vaccinated
COVID-19.
Material
methods
One
thousand
six
hundred
sixty-eight
were
observed.
Over
2
years,
5,082
IgG
IgM
antibody
samples
determined.
concentration
antibodies
was
assessed
groups
patients:
those
undergoing
therapy
contracting
COVID-19
vaccination
infection.
Results
obtained
results
indicate
naturally
more
significant
who
not
undergone
such
as
radiotherapy,
chemotherapy,
or
surgical
intervention.
observation
applies
breast,
lung,
colon,
kidney,
testicular
cancer,
although
varies
significantly
depending
type
cancer.
Graphical
abstract
Language: Английский